SGLT2 Inhibitors and Diabetic Ketoacidosis: What You Need to Know About the Hidden Risk
SGLT2 inhibitors help manage type 2 diabetes but carry a hidden risk: euglycemic diabetic ketoacidosis (euDKA), where ketones rise even with normal blood sugar. Learn the symptoms, who's at risk, and how to prevent this life-threatening complication.
- Nov, 20 2025
- 9 Comments